Best Immunotherapy with Keytruda (Pembolizumab) Doctors in Turkey for Australians

Dr. Bulent Karagoz is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in immunotherapy and targeted therapies for sarcoma, lymphoma, and lung cancer. Dr. Karagoz provides treatment at a facility affiliated with the prestigious Johns Hopkins Hospital.

• Authored over 40 research publications focusing on tumor biology and immunology.
• Former Head of Internal Diseases at Istanbul Okan University Faculty of Medicine.
• Held leadership roles in medical oncology at GATA Haydarpasa Training Hospital.
• Member of the Turkish Medical Oncology Association and European Head and Neck Society.

Dr. Eda Tanrikulu is a clinical oncologist at Anadolu Medical Center in Istanbul. She ranked 3rd nationally in Turkey's minor specialty medical exam. Dr. Tanrikulu specializes in chemotherapy and individualized cancer treatments. She works at a facility affiliated with the Johns Hopkins Hospital.

• Served as the head of the medical oncology unit at Haydarpaşa Numune Hospital.
• Participated in global training at Oxford University and ESMO in Manchester.
• Treats gastrointestinal, urological, lung, and breast cancers.
• Member of the American and European Societies of Medical Oncology.

Dr Mustafa Solak brings elite international expertise to immunotherapy cases, having refined his skills at the University of Texas MD Anderson Cancer Center in the USA.

• Performed over 1,100 cancer treatments using modern systemic protocols
• Completed an advanced fellowship at the Hacettepe University Cancer Institute
• Specialises in managing advanced malignancies with targeted therapy and Keytruda
• Practises at Hisar Hospital Intercontinental focusing on lung and gastrointestinal cancers
• Extensive background in coordinating complex care for solid tumours and sarcomas

Associate Professor Abdullah Sakin is the former Head of Medical Oncology at Yüzüncü Yıl University Faculty of Medicine and currently leads medical oncology at Medipol Bahçelievler Hospital.

• Specialises in internal medicine and medical oncology with a focus on advanced cancer therapies
• Served as Education Officer at the Prof Dr Cemil Taşçıoğlu City Hospital medical oncology clinic
• Contributes to clinical research and the education of future oncology specialists
• Recognised for managing complex cases within Turkish university and training hospital systems

Dr. Sinan Karaaslan is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, colorectal, and urogenital system cancers. Dr. Karaaslan brings clinical expertise from major institutions, including Medical Park and Gülhane Military Medical Academy. He works at a hospital affiliated with the Johns Hopkins Hospital.

• Holds personal certification from the European Society for Medical Oncology.
• Treats complex conditions, including stage 4 colon and lung cancers.
• Member of the Turkish Medical Oncology and Turkish Lung Cancer societies.
• Performs systemic therapies such as immunotherapy, targeted therapy, and chemotherapy.

Professor Yesim Yildirim is an ESMO-certified medical oncologist who completed specialised immuno-oncology training at the Mount Vernon Cancer Centre in the UK.

• Holds a prestigious ESMO examination certificate and the rank of Professor
• Completed an advanced immunology course in Switzerland via a Hans Wyder fellowship
• Founded the Turkish Gastrointestinal Oncology Network to improve regional treatment standards
• Member of the American Society of Clinical Oncology (ASCO)
• Authored over 80 scientific works on precision medicine and advanced cancer care

Dr. Seref Komurcu is a medical oncologist at Anadolu Medical Center in Istanbul. He specializes in treating breast, lung, colorectal, and solid cancers. Dr. Komurcu holds both ECFMG and ESMO certifications. He previously served as a professor at Gülhane Military Medical Academy.

• Published over 110 scientific papers on cancer management.
• Provides immunotherapy, targeted therapy, and chemotherapy treatments.
• Member of the American Society of Clinical Oncology.
• Works at a clinic affiliated with Johns Hopkins Medicine.

Dr. Necdet Uskent is a medical oncologist and hematologist at Anadolu Medical Center in Istanbul. He was part of the pioneering team that performed Turkey's first bone marrow transplant. Dr. Uskent holds the European Medical Oncology Certificate and focuses on breast, lung, and gastrointestinal cancers. He works at a facility affiliated with Johns Hopkins Medicine.

• Founder of the Turkish Oncology Group (TOG).
• A founding member of the Turkish Society of Medical Oncology.
• Served as a visiting lecturer at Royal Free and University College Hospital in London.
• Treats complex hematological conditions including lymphomas and myeloma.

Dr Tahsin Ozadli has performed over 1,100 cancer treatments and specialises in advanced medical oncology at Valued Med Hub Hospitals.

• Completed specialist oncology training at the prestigious Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital
• Focuses on complex immunotherapy cases for lung, breast, and gastric cancers
• Recognised for academic contributions with research published on Google Scholar
• Previously served as a clinical oncologist at leading regional training and research hospitals

Associate Professor Tahsin Ozatli is a specialist medical oncologist at Istinye University Liv Hospital with a focus on targeted therapies for complex cancers.

• Specialises in treatment plans for breast, lung, and gastrointestinal malignancies
• Achieved the rank of Associate Professor in 2016 for his contributions to oncology
• Gained extensive expertise at the dedicated Ankara Oncology Clinic
• Trained at the Regional Training and Research Hospital in Erzurum
• Expert in managing systemic treatments across diverse internal medicine cases

Professor Mustafa Serkan Alemdar is a medical oncology specialist at Medical Park Antalya with deep roots in academic medicine at Akdeniz University.

• Triple-specialised in medicine, internal medicine, and medical oncology
• Served as a senior specialist at Akdeniz University Hospital for over a decade
• Expertise includes modern immunotherapy protocols for complex solid tumours
• Active researcher in the field of clinical oncology and patient outcomes

Professor Irfan Cicin is a senior medical oncologist and academic lead at Trakya University Faculty of Medicine, where he oversees complex cancer treatment protocols.

• Specialised in medical oncology at Trakya University, focusing on modern drug therapies
• Holds the title of Professor of Medical Oncology, the highest academic rank in Turkey
• Served as a physician for the Turkish Air Force Command at Etimesgut Military Hospital
• Practises at İstinye University Liv Hospital Topkapı, a major centre for oncology research
• Expertise includes managing targeted immunotherapy regimes for various solid tumour types

Associate Professor Nail Paksoy is a Board Certified medical oncologist who specialises in immunotherapy and advanced cancer clinical trials.

• ESMO Board Certified in Medical Oncology, recognised by the professional body for oncology in Europe
• Serves as a Sub-Investigator for multiple international clinical trials involving Pembrolizumab (Keytruda)
• Completed a specialised fellowship in Allergy and Immunology, providing deep insight into immune system responses
• Associate Professor at Medipol University, where he contributes to the next generation of cancer specialists

Professor Ercan Ozden is a dual-qualified specialist in internal medicine and medical oncology at VM Medical Park Pendik Hospital.

• Completed the English Medical Programme at Istanbul University Cerrahpasa Faculty of Medicine
• Expert in medical oncology subspecialty focusing on targeted systemic therapies
• Manages complex treatment plans involving immunotherapy for various solid tumours
• Trained at Kocaeli University Faculty of Medicine in advanced oncological care

Associate Professor Muhammed Mustafa Atci is a leading medical oncologist at İstinye University Liv Hospital with a strong focus on advanced immunotherapy protocols.

• Coordinates medical oncology education for the Ministry of Health – teaching the next generation of specialists
• Expert in treating residual triple-negative breast cancer with targeted chemotherapy and immunotherapy combinations
• Active researcher in BRCA mutation profiles and hereditary cancer risks
• Member of the American Society of Clinical Oncology (ASCO) since 2018
• Published extensive research on survival impacts of emerging treatments in international peer-reviewed journals

Associate Professor Ayse Irem Yasin is an ESMO-certified board oncologist who specialises in immunotherapy targets for solid tumours at Medipol Acibadem District Hospital.

• Holds a European Society for Medical Oncology (ESMO) Board Certificate from Paris
• Completed a specialised breast cancer unit residency at Maggiore della Carita Hospital in Italy
• Gained clinical experience at world-leading institutions including Harvard Medical School and Cleveland Clinic
• Expertise covers complex immunotherapy applications for lung, gastrointestinal, and gynaecological cancers

Professor Serdar Bedii Omay is a dual-qualified haematologist and oncologist who earned his PhD from Japan Mie Medical School. He specialises in treating resistant blood cancers at Emsey Hospital.

• Manages immunotherapy protocols for resistant Non-Hodgkin and Hodgkin lymphoma cases
• Expert in CAR T-cell therapy and molecular haematology research
• Published over 65 scientific articles in international medical journals
• Former Professor of Haematology at two leading Turkish universities
• Member of the bone marrow transplant unit featuring 45 high-intensity care beds

Professor Birol Baytan has performed 950 bone marrow transplants and leads one of Turkey's largest paediatric transplant units at Emsey Hospital.

• Specialises in managing complex solid tumours including neuroblastoma, brain tumours, and Ewing sarcoma
• Provides immunotherapy with Keytruda alongside advanced CAR T-cell therapy protocols
• Expert in identifying genetic changes in cancer cells through cytogenetic studies
• Published 15 articles in international medical journals on paediatric blood disorders
• Author of three medical books focused on childhood health and oncology

Dr. Osman Ilhan was part of the team that performed Turkey's first bone marrow stem cell transplant. He focuses on leukemia, Hodgkin lymphoma, and myeloma treatments at Private Koru Ankara Hospital. Dr. Ilhan has authored over 300 PubMed publications with 5,000+ citations. He holds the Platinum CME certificate from the European Hematology Association.

• Helped establish the Turkish Stem Cell Donor Bank (TURKOK).
• Served as a board chairman for bone marrow transplantation at the Ministry of Health.
• Former President of the Turkish Hematology Association.
• Founded the Cellular Therapy and Regenerative Medicine Association.